Published in
European Urology Open Science, (19), p. e1266-e1267, 2020
DOI: 10.1016/s2666-1683(20)33434-0
Links
Tools
Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score
Journal article published in 2020 by
M. Carmen Mir,
M. C. Mir Maresma,
Alessandro Veccia,
Michele Marchioni,
Riccardo Campi,
Andrea Minervini,
Maximilian Kriegmair,
Matthias Heck,
Francesco Porpiglia,
Eduard Roussel 
,
Siska Van Bruwaene,
Michele Musquera,
Estefania Linares,
Maarteen Albertsen,
Enrico Checcucci
and other authors.
,
Siska Van Bruwaene,
Michele Musquera,
Estefania Linares,
Maarteen Albertsen,
Enrico Checcucci
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 